MIF has been shown to promote cell proliferation and tumor angiogenesis [13], and over-expression of MIF has been reported in various types of cancers, including prostate tumors, breast cancer, colon carcinomas, HCCs, and glioblastoma. Here, MIF is linked to breast cancer.